Thermo Fisher Scientific Inc. Stock Mexican S.E.
Equities
TMO *
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,946 MXN | +2.68% | +2.07% | +9.87% |
05-10 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
05-10 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 43.01B 724B 58.7B | Sales 2025 * | 46.08B 776B 62.89B | Capitalization | 225B 3,797B 308B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 103B 8.34B | Net income 2025 * | 7B 118B 9.55B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 23.99B 404B 32.74B | Net Debt 2025 * | 19.18B 323B 26.18B | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
31.8
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | +2.68% | ||
1 week | +2.07% | ||
Current month | +1.91% | ||
1 month | +5.49% | ||
3 months | +6.60% | ||
6 months | +24.64% | ||
Current year | +9.87% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9,946 | +2.68% | 49 |
24-05-08 | 9,686 | +0.16% | 64 |
End-of-day quote Mexican S.E., May 09, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B | |
+25.48% | 32.01B |
- Stock Market
- Equities
- TMO Stock
- TMO * Stock